{
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "document": {
    "pdf_name": "CDC_Influenza_vaccines",
    "source_pdf": "data/clinical_files/CDC Influenza vaccines.pdf",
    "total_pages": 2,
    "total_blocks": 23,
    "total_characters": 2237
  },
  "extraction_result": {
    "success": true,
    "total_snippets_found": 1,
    "error": null
  },
  "extracted_evidence": [
    {
      "id": 1,
      "quote": "Flublok Quadrivalent (RIV4, recombinant HA vaccine) was evaluated in a pivotal clinical trial against Fluarix Quadrivalent (standard-dose, egg-based vaccine).",
      "relevance_explanation": "This quote directly states that Flublok Quadrivalent was evaluated in a pivotal trial against Fluarix Quadrivalent, which is a standard-dose vaccine, thus supporting the claim."
    }
  ],
  "model_used": "gpt-4.1"
}